Article
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales
3 Feb 2021
Abstract excerpt
BACKGROUND: Imipenem/relebactam is a novel carbapenem/β-lactamase inhibitor combination, developed to act against carbapenemase-producing Enterobacterales (CPE). OBJECTIVES: To assess the in vitro activity of imipenem/relebactam against a Spanish nationwide collection of CPE by testing the susceptibility of these isolates to 16 widely used antimicrobials and to determine the underlying β-lactam resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
